UPDATED May 20, 2024
Discover U.S. High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AEHL | US$1.41 | -8.8% | -90.8% | US$12.2m | n/a | PB0.9x | n/a | 0% | Media | ||
FENG | US$1.97 | -1.6% | -16.3% | US$24.4m | n/a | PB0.1x | n/a | 0% | Media | ||
PRPH | US$5.24 | -0.9% | -40.9% | US$96.0m | US$18.50 | PS3.5x | E97.4% | 0% | Pharmaceuticals & Biotech | ||
PRA | US$14.39 | -0.8% | 13.8% | US$756.5m | US$17.50 | PB0.7x | E124.6% | 0% | Insurance | ||
CLF | US$17.71 | 0.06% | 19.1% | US$8.3b | US$20.79 | PE21.6x | E35.6% | 0% | Materials | ||
KOS | US$6.27 | 4.3% | -4.4% | US$2.8b | US$8.52 | PE13.3x | E13.5% | 0% | Energy | ||
SRG | US$6.07 | -10.5% | -20.7% | US$345.5m | US$9.50 | PS14.5x | n/a | 0% | Real Estate Management and Development | ||
NBR | US$79.41 | 7.4% | -15.2% | US$725.2m | US$104.78 | PB2.6x | E108.7% | 0% | Energy | ||
PW | US$0.69 | 22.3% | -69.8% | US$2.2m | n/a | PB0.1x | n/a | 0% | Real Estate | ||
BLKB | US$79.60 | 2.9% | 9.2% | US$4.0b | US$84.29 | PE184.8x | E31.2% | 0% | Software | ||
OI | US$13.15 | -3.5% | -40.6% | US$2.1b | US$18.11 | PB1.2x | E44.3% | 0% | Materials | ||
CRK | US$11.35 | 9.6% | 8.5% | US$3.2b | US$10.13 | PE54.3x | E71.2% | 0% | Energy | ||
ADTN | US$5.27 | -4.9% | -42.2% | US$415.5m | US$7.50 | PB1.6x | E97.3% | 0% | Tech | ||
TAL | US$12.62 | -7.5% | 115.0% | US$8.3b | US$16.10 | PS5.4x | E42.1% | 0% | Consumer Services | ||
CCM | US$0.60 | 10.9% | -56.2% | US$21.8m | n/a | PE-0.6x | n/a | 0% | Healthcare | ||
INVA | US$16.13 | -0.4% | 18.3% | US$997.9m | US$16.00 | PE5.6x | S5.8% | 0% | Pharmaceuticals & Biotech | ||
BA | US$186.61 | 4.6% | -9.4% | US$113.5b | US$221.92 | PS1.5x | E53.9% | 0% | Capital Goods | ||
DXC | US$16.21 | -17.0% | -34.5% | US$3.0b | US$18.71 | PE31.9x | E57.5% | 0% | Software | ||
NCMI | US$4.91 | 8.4% | 55.9% | US$477.1m | US$6.08 | PE0.7x | E-111.4% | 0% | Media | ||
BBGI | US$0.72 | -0.9% | -35.0% | US$21.6m | US$2.50 | PB0.1x | E138.3% | 0% | Media | ||
TATT | US$13.63 | 6.4% | 128.7% | US$132.6m | n/a | PE29.5x | n/a | 0% | Capital Goods | ||
ACR | US$13.08 | -0.2% | 58.9% | US$95.3m | US$17.75 | PE16x | E29.8% | 0% | Diversified Financials | ||
KAR | US$17.54 | -1.4% | 14.3% | US$1.9b | US$19.83 | PS1.2x | E128.2% | 0% | Commercial Services | ||
AZTA | US$51.48 | 0.3% | 17.5% | US$2.7b | US$62.60 | PS4.3x | E83.8% | 0% | Pharmaceuticals & Biotech |